148 related articles for article (PubMed ID: 36649984)
1. [Chinese expert consensus on iodine-125 seed implantation for locally advanced differentiated thyroid cancer(2023 edition)].
;
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):149-157. PubMed ID: 36649984
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of adverse reactions and complications in Chinese expert consensus of Iodine-125 brachytherapy for pancreatic cancer.
Li Q; Liang Y; Zhao Y; Gai B
J Cancer Res Ther; 2019; 15(4):751-754. PubMed ID: 31436227
[TBL] [Abstract][Full Text] [Related]
3. Chinese expert consensus on radioactive
Gai B; Zhang F
J Cancer Res Ther; 2018; 14(7):1455-1462. PubMed ID: 30589023
[TBL] [Abstract][Full Text] [Related]
4. Chinese expert consensus workshop report: Guideline for permanent iodine-125 seeds implantation of primary and metastatic lung tumors (2020 edition).
Zhang F; Wang J; Guo J; Huang X; Guan Z; Lei G; Wang J; Ye X; Zhao X; Wang J; Wang R; Liu B; Zhou Q; Zhao M; Wang C; Li Y
J Cancer Res Ther; 2020; 16(7):1549-1554. PubMed ID: 33565498
[TBL] [Abstract][Full Text] [Related]
5. Chinese Expert Consensus Workshop Report: Guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors.
Zhang F; Wang J; Guo J; Li Y; Huang X; Guan Z; Lei G; Wang J; Ye X; Zhao X; Wang J; Wang R; Liu B
Thorac Cancer; 2019 Feb; 10(2):388-394. PubMed ID: 30521144
[TBL] [Abstract][Full Text] [Related]
6. Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.
Boucher A; Ezzat S; Hotte S; Rachinsky I; Rajaraman M; Ruether D; Wiseman SM; Brierley J; Ho C; Krzyzanowska M; Lamond N; Massicotte MH; Joseph S; Herscovitch K; Sikora L; Winquist E
Oral Oncol; 2021 Oct; 121():105477. PubMed ID: 34388408
[TBL] [Abstract][Full Text] [Related]
7. Chinese Expert Consensus on Iodine
Jiang P; Zou L; Wei L; Cheng G; Sun B; Zhang F; Wang R; Wang T; Qu A; Yuan X; Qiu B; Wei S; Liu Z; Zhang Y; Wang J
Front Oncol; 2021; 11():700710. PubMed ID: 34858802
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for radioiodine therapy of differentiated thyroid cancer.
Luster M; Clarke SE; Dietlein M; Lassmann M; Lind P; Oyen WJ; Tennvall J; Bombardieri E;
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1941-59. PubMed ID: 18670773
[TBL] [Abstract][Full Text] [Related]
9. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.
Ciarallo A; Rivera J
AJR Am J Roentgenol; 2020 Aug; 215(2):285-291. PubMed ID: 32551904
[No Abstract] [Full Text] [Related]
10. Low-iodine tube-feeding diet for iodine-131 scanning and therapy.
Ain KB; Dewitt PA; Gardner TG; Berryman SW
Clin Nucl Med; 1994 Jun; 19(6):504-7. PubMed ID: 8062468
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-guided implantation of radioactive
Chen W; Luo YK; Zhang Y; Song Q; Tang J
BMC Cancer; 2021 Jul; 21(1):834. PubMed ID: 34284748
[TBL] [Abstract][Full Text] [Related]
12. [Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
Dong FH
Zhongguo Gu Shang; 2018 Jun; 31(6):493-496. PubMed ID: 29945400
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
14. Expert consensus statement on computed tomography-guided
Wang J; Chai S; Zheng G; Jiang Y; Ji Z; Guo F; Zhuang H; Zhang K
J Cancer Res Ther; 2018 Jan; 14(1):12-17. PubMed ID: 29516952
[TBL] [Abstract][Full Text] [Related]
15. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
[TBL] [Abstract][Full Text] [Related]
16. Expert consensus on computed tomography-assisted three-dimensional-printed coplanar template guidance for interstitial permanent radioactive
Wang J; Chai S; Wang R; Zheng G; Zhang K; Huo B; Huo X; Jiang Y; Ji Z; Jiang P; Peng R
J Cancer Res Ther; 2019; 15(7):1430-1434. PubMed ID: 31939420
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI; Bischoff L; Ball D; Bernet V; Blomain E; Busaidy NL; Campbell M; Dickson P; Duh QY; Ehya H; Goldner WS; Guo T; Haymart M; Holt S; Hunt JP; Iagaru A; Kandeel F; Lamonica DM; Mandel S; Markovina S; McIver B; Raeburn CD; Rezaee R; Ridge JA; Roth MY; Scheri RP; Shah JP; Sipos JA; Sippel R; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Yeh M; Cassara CJ; Darlow S
J Natl Compr Canc Netw; 2022 Aug; 20(8):925-951. PubMed ID: 35948029
[TBL] [Abstract][Full Text] [Related]
18. The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.
Nixon IJ; Shah JP; Zafereo M; Simo RS; Hay ID; Suárez C; Zbären P; Rinaldo A; Sanabria A; Silver C; Mäkitie A; Vander Poorten V; Kowalski LP; Shaha AR; Randolph GW; Ferlito A
Eur J Surg Oncol; 2020 May; 46(5):754-762. PubMed ID: 31952928
[TBL] [Abstract][Full Text] [Related]
19. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of preoperative radioactive iodine (131I) therapy for locally advanced papillary thyroid cancer: a case report.
Shingu K; Kobayashi S; Yokoyama S; Shimizu T; Kasuga Y; Fujimori M; Ito K; Hama Y; Amano J
Thyroid; 1998 Dec; 8(12):1113-6. PubMed ID: 9920366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
